3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Urinary Bladder Neoplasms
2
Ureteral Neoplasms
2
Carcinoma, Transitional Cell
2
Urothelial Cancer
1
Urologic Neoplasms
1
Urethral Neoplasms
1
Triple Negative Breast Neoplasms
1
Metastatic Urothelial Cancer
1
Head and Neck Neoplasms
1
Esophageal Neoplasms
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms
1
Interventions
durvalumab
2
Magnetic Resonance Imaging
2
Electrocardiography
2
Diphenhydramine
2
Cystoscopy
2
Biopsy
2
Acetaminophen
2
valrubicin
1
fludarabine phosphate
1
fludarabine
1
aldesleukin
1
Tomography, X-Ray Computed
1
Standard of Care
1
Respiratory Function Tests
1
Prochlorperazine
1
Positron-Emission Tomography
1
Ondansetron
1
O(6)-codeine methyl ether
1
Nicotine Replacement Therapy
1
Mitomycin
1
Meperidine
1
Loperamide
1
Interleukin-2
1
Innovar
1
Indomethacin
1
Hydroxyzine
1
Histamine Antagonists
1
Granisetron
1
Gemcitabine
1
Erlotinib Hydrochloride
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Carcinoma in Situ
×
enfortumab vedotin
×
Clear all
No trials found.